Incannex Healthcare Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 12

Employees

  • Stock Symbol
  • IXHL

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $1.97
  • (As of Friday Closing)

Incannex Healthcare General Information

Description

Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.

Contact Information

Formerly Known As
Mount Magnet South Ltd, Impression Healthcare
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 8 Century Circuit
  • Suite 105, Norwest
  • Sydney, New South Wales 2153
  • Australia
+61 0409
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Corporate Office
  • 8 Century Circuit
  • Suite 105, Norwest
  • Sydney, New South Wales 2153
  • Australia
+61 0409

Incannex Healthcare Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Incannex Healthcare Stock Performance

As of 13-Nov-2026, Incannex Healthcare’s stock price is $1.97. Its current market cap is $24.7M with 12.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.97 $2.02 $1.91 - $14.91 $24.7M 12.5M 84.8K -$1.25

Incannex Healthcare Financials Summary

As of 30-Sep-2026, Incannex Healthcare has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV (26,970) (29,349) 15,186 37,771
Revenue 0 0 86 12
EBITDA (15,083) (19,083) (46,398) (18,532)
Net Income (14,833) (19,302) (46,885) (18,459)
Total Assets 70,394 72,979 20,447 17,047
Total Debt 83 96 258 373
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Incannex Healthcare Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Incannex Healthcare‘s full profile, request access.

Request a free trial

Incannex Healthcare Patents

Incannex Healthcare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024900439-A0 A method of treatment Inactive 23-Feb-2024
AU-2023903778-A0 A composition and uses thereof Inactive 23-Nov-2023
AU-2024383625-A1 Composition comprising tetrahydrocannabinol and acetazolamide in a fixed dose combination capsule Pending 23-Nov-2023
EP-4812154-A1 Composition comprising tetrahydrocannabinol and acetazolamide in a fixed dose combination capsule Pending 23-Nov-2023
WO-2025107039-A1 Composition comprising tetrahydrocannabinol and acetazolamide in a fixed dose combination capsule Inactive 23-Nov-2023 A61K9/5084
To view Incannex Healthcare’s complete patent history, request access »

Incannex Healthcare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Incannex Healthcare Investments & Acquisitions (4)

Incannex Healthcare’s most recent deal was a Joint Venture with Mind Medicine Australia Clinic. The deal was made on 17-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mind Medicine Australia Clinic 17-Jun-2025 Joint Venture Clinics/Outpatient Services
APIRx Pharmaceuticals 05-Aug-2022 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Gameday International 20-Oct-2016 Merger/Acquisition Other Consumer Durables
Adaman Resources (Kirkalocka Gold Mine in Australia) 10-Jan-2008 Corporate Asset Purchase Buildings and Property
To view Incannex Healthcare’s complete investments and acquisitions history, request access »

Incannex Healthcare ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

42.28 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Incannex Healthcare’s complete esg history, request access »

Incannex Healthcare Exits (1)

Incannex Healthcare’s most recent exit was on 10-Jan-2008 from Adaman Resources (Kirkalocka Gold Mine in Australia). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Adaman Resources (Kirkalocka Gold Mine in Australia) 10-Jan-2008 Completed
To view Incannex Healthcare’s complete exits history, request access »

Incannex Healthcare Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
APIRx Pharmaceuticals New York, NY 2003

Incannex Healthcare FAQs

  • When was Incannex Healthcare founded?

    Incannex Healthcare was founded in 2001.

  • Where is Incannex Healthcare headquartered?

    Incannex Healthcare is headquartered in Sydney, Australia.

  • What is the size of Incannex Healthcare?

    Incannex Healthcare has 12 total employees.

  • What industry is Incannex Healthcare in?

    Incannex Healthcare’s primary industry is Drug Discovery.

  • Is Incannex Healthcare a private or public company?

    Incannex Healthcare is a Public company.

  • What is Incannex Healthcare’s stock symbol?

    The ticker symbol for Incannex Healthcare is IXHL.

  • What is the current stock price of Incannex Healthcare?

    As of 13-Nov-2026 the stock price of Incannex Healthcare is $1.97.

  • What is the current market cap of Incannex Healthcare?

    The current market capitalization of Incannex Healthcare is $24.7M.

  • What is Incannex Healthcare’s annual earnings per share (EPS)?

    Incannex Healthcare’s EPS for 12 months was -$1.25.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process